Loading company…
RedShift BioAnalytics develops analytical instruments for protein therapeutic research and manufacturing.
Founded in 2005 and based in Burlington, RedShift BioAnalytics develops analytical instruments for biopharmaceutical companies. Its products include Microfluidic Modulation Spectroscopy technology and the HaLCon real-time titer measurement platform. In October 2021, it raised USD 10.00 mn in Series E funding led by Illumina Ventures, with Technology Venture Partners and Waters Corporation participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in